Clinical trials
Proteinuria trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 4 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 4 |
| 2016 | 2 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 13 |
| Recruiting | 6 |
| Terminated | 2 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Children's Hospital of Fudan University | 4 |
| Nanjing University School of Medicine | 4 |
| Fudan University | 3 |
| The University of Hong Kong | 3 |
| Alexion Pharmaceuticals, Inc. | 2 |
| Chinese PLA General Hospital | 2 |
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| Chen Xiangmei | 1 |
| Daiichi Sankyo Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Proteinuria | 39 |
| Glomerulonephritis, IGA | 12 |
| Renal Insufficiency, Chronic | 7 |
| Diabetic Nephropathies | 3 |
| Kidney Diseases | 3 |
| Anemia | 2 |
| Anemia, Aplastic | 2 |
| Anemia, Hemolytic | 2 |
| Bone Marrow Failure Disorders | 2 |
| Diabetes Mellitus, Type 2 | 2 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.